Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hurtz

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Cancers|June 26, 2026
Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian CancerAshlyn Conant, Kayla Sanchez, Shreya Patil, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy StrategyV S S Abhinav Ayyadevara, Shikha Gaur, Ashley Paik, et al.
Nature Communications|October 19, 2017
Extrafollicular CD4<sup>+</sup> T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host diseaseRuishu Deng, Christian Hurtz, Qingxiao Song, et al.
The Journal of Experimental Medicine|March 13, 2013
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemiaReshmi Parameswaran, Min Lim, Anna Arutyunyan, et al.
JCI Insight|October 31, 2023
Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesisYing Ting Sit, Kaoru Takasaki, Hyun Hyung An, et al.
Blood|November 16, 2012
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemiaParham Ramezani-Rad, Huimin Geng, Christian Hurtz, et al.
Molecular Oncology|July 10, 2026
Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancerAshlyn Conant, Tise Suzuki, Kiera McGivney, et al.
Genes & Development|August 10, 2019
Rationale for targeting BCL6 in <i>MLL</i>-rearranged acute lymphoblastic leukemiaChristian Hurtz, Lai N Chan, Huimin Geng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemiaBehzad Kharabi Masouleh, Huimin Geng, Christian Hurtz, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood|December 30, 2016
Ibrutinib inhibits pre-BCR<sup>+</sup> B-cell acute lymphoblastic leukemia progression by targeting BTK and BLKEkaterina Kim, Christian Hurtz, Stefan Koehrer, et al.
Cancers|June 26, 2026
Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian CancerAshlyn Conant, Kayla Sanchez, Shreya Patil, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy StrategyV S S Abhinav Ayyadevara, Shikha Gaur, Ashley Paik, et al.
Nature Communications|October 19, 2017
Extrafollicular CD4<sup>+</sup> T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host diseaseRuishu Deng, Christian Hurtz, Qingxiao Song, et al.
The Journal of Experimental Medicine|March 13, 2013
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemiaReshmi Parameswaran, Min Lim, Anna Arutyunyan, et al.
JCI Insight|October 31, 2023
Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesisYing Ting Sit, Kaoru Takasaki, Hyun Hyung An, et al.
Blood|November 16, 2012
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemiaParham Ramezani-Rad, Huimin Geng, Christian Hurtz, et al.
Molecular Oncology|July 10, 2026
Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancerAshlyn Conant, Tise Suzuki, Kiera McGivney, et al.
Genes & Development|August 10, 2019
Rationale for targeting BCL6 in <i>MLL</i>-rearranged acute lymphoblastic leukemiaChristian Hurtz, Lai N Chan, Huimin Geng, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemiaBehzad Kharabi Masouleh, Huimin Geng, Christian Hurtz, et al.
Pageof 3